A California jury has awarded pharmaceutical drug company Merck $200 million, a fraction of what it had sought, for infringement of two of its patents
Tag: patents on wall street
Validated Merck patents could mean a $3B+ windfall, after appeals
While many high-tech patents are suffering from devaluation the value of some pharmaceutical patents is soaring. Merck & Co. won a legal victory over
“Secrets” is required reading for informed managers and investors
In an information age that worships data and transparency, the trade or business secret has never been more valuable. “Secrets” is an essential guide to
Technology companies back as top patent defendants in 2016
While it may seem like all of the patent infringement targets are large technology companies in 2015, at least 7 of the top 10 defendants
Burford Capital, Digimarc and Imagination added to IP CloseUp 30
Three public companies that are active in patent licensing or highly dependent on patents for success have been added to the IP CloseUp 30 index
PTAB instituted IPRs are flat after declining slightly in 2015
After declining 9% in 2015 from the 2014 fiscal year Patent Trial and Appeal Board-instituted inter partes reviews (IPRs) have leveled off. Instituted reviews were at 74%
The bonds that fell to earth – The financial magic of David Bowie
The passing of David Bowie is a reminder that he was an innovator in finance and intellectual property, as well as music and fashion. Much has
Annual report: IP CloseUp visits are up 32% in 2015 to 24,000
2015 was a year of growth for IP CloseUp, as visits increased to 24,000 and subscriptions were up, too. The busiest day of the year
Angry musicians are pushing back on royalties – Will inventors follow?
Song writers may have something to teach inventors when it comes to getting a fair share for their intellectual property rights, or not. Confusion
Patent quality — Is a “shared responsibility”, says IBM; it does not represent invention quality or IP value
There is a great deal of agreement that patent quality is lacking, but surprisingly little about how to define and achieve it. Patent quality is
“IP Finance 2015” will examine IP assets, transactions and challenges
IP Finance 2015, “Innovative Ways to Manage IP Assets for Maximum Return,” will bring together in New York on May 14 leaders in patent licensing
Rohrabacher to Congress: “Don’t let the ‘Innovation Act’ be a part of our legacy”
Not everyone agrees that another round of patent reform is necessary at this time. Doubters believe that the Innovation Act, H.R. 9 in its current form, will
ipcloseup.com 